Key Insights

Highlights

Success Rate

88% trial completion (above average)

Treatment Research

15 treatments under study, led by Project Voice

Research Leaders

15 sponsors active, led by National Cancer Institute (NCI)

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

87.5%

+0.9% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (7)
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed7
Unknown2
Suspended1
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (11)

Research Network

Common Treatments

  • Project Voice2
  • Practice Facilitation1
  • Hpv Informational Video1
  • Standard Messages1
  • Hpv Vaccine1

Active Sponsors

  • National Cancer Institute (NCI)5
  • Parkland Health and Hospital System2
  • Southern Methodist University2
  • Fujian Maternity and Child Health Hospital2
  • University of Texas Southwestern Medical Center2

Top Investigators

Related Conditions

  • Adverse Effect2
  • Woman2
  • China2
  • Attitude To Health1
  • Adolescent Health Services1

Activity Timeline